BRAF and hepatocellular carcinoma: Notably, in human medicine, BRAF mutations are recognised for their diagnostic and predictive significance in thyroid carcinomas [32], pulmonary carcinomas [33], colorectal carcinomas [34], and hepatocellular carcinomas [35], while in contrast, our tested samples in these specific cancer types tested negative for the BRAF mutation.